Company Filing History:
Years Active: 2022
Title: Alexander Azrilevich: Innovator in Cancer Treatment
Introduction
Alexander Azrilevich is a notable inventor based in Princeton, NJ (US). He has made significant contributions to the field of cancer treatment through his innovative research and development. His work focuses on the application of monoclonal antibodies in combination with specific compounds to enhance therapeutic outcomes for cancer patients.
Latest Patents
Azrilevich holds a patent for "Compositions and methods of treating cancer." This patent outlines methods for treating cancer in subjects using a combination of a monoclonal antibody and (R)-N-(4-chlorophenyl)-2-(cis-4-(6-fluoroquinolin-4-yl)cyclohexyl)propanamide, or a salt thereof. This innovative approach aims to improve the efficacy of cancer treatments.
Career Highlights
Throughout his career, Azrilevich has been associated with Bristol-Myers Squibb Company, a leading biopharmaceutical company. His work there has allowed him to contribute to groundbreaking research in oncology and develop new treatment methodologies.
Collaborations
He has collaborated with esteemed colleagues such as Paul Andrew Basciano and Justine Kamilah Walker. These partnerships have fostered a collaborative environment that enhances the research and development of cancer therapies.
Conclusion
Alexander Azrilevich is a prominent figure in the field of cancer treatment, with a focus on innovative methodologies that combine monoclonal antibodies with specific compounds. His contributions through patents and collaborations continue to advance the fight against cancer.